Dr Lal Pathlabs Gains 0.74%: Mixed Technical Signals and Valuation Concerns Shape the Week
2026-11-21 14:01:48Key Events This Week 16 Nov: Stock opens at Rs.2,004.90, up 0.66% 17 Nov: Downgrade to Hold by MarketsMOJO announced 18 Nov: Technical momentum shifts to mildly bullish; stock dips 1.26% 20 Nov: Stock rebounds 2.26% to close at Rs.2,006.55 Week OpenRs.1,991.75 Week CloseRs.2,006.55<div cl...
Read More
Dr Lal Pathlabs Downgraded to Hold Amid Mixed Technical and Valuation Signals
2026-11-18 08:31:21Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has seen its investment rating downgraded from Buy to Hold as of 17 Nov 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. While the company continues to demonstrate strong financial metrics and market-beating returns, evolving technical signals and stretched valuations have tempered investor enthusiasm.
Read More
Dr Lal Pathlabs Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-11-18 08:04:42Dr Lal Pathlabs Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of mid-November 2026. Despite a modest decline in the stock price on 18 Nov 2026, the underlying technical indicators present a complex picture, reflecting both cautious optimism and emerging bearish signals within the healthcare services sector.
Read More
Dr Lal Pathlabs Ltd is Rated Buy by MarketsMOJO
2026-11-15 10:10:41Dr Lal Pathlabs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 3 November 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 15 November 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance.
Read More
Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 2061.5
2026-11-09 10:12:26Surging to an intraday peak of Rs 2061.5 on 09 Nov 2026, Dr Lal Pathlabs Ltd has marked a fresh 52-week high, propelled by a confluence of robust technical indicators and sustained price momentum. This milestone caps a notable rally that has delivered 32.91% returns over the past year, comfortably outpacing the Sensex’s decline of 2.87% during the same period.
Read MoreDr Lal Pathlabs Gains 3.14%: 5 Key Factors Driving the Week’s Momentum
2026-11-07 14:02:09Key Events This Week Nov 2: Stock opens at Rs.1,887.50, down 0.99% amid broader Sensex gains Nov 3: Mojo Grade upgraded to Buy by MarketsMOJO on strong metrics Nov 4: New 52-week high touched intraday at Rs.2,013.60, closing near record levels Nov 5: New 52-week high of Rs.2,050 reached, despite intraday pullback Nov 6: Week closes at Rs.1,966.25, marginally down from previous day <div ...
Read More
Dr Lal Pathlabs Ltd Reports Flat Quarterly Performance Amid Mixed Financial Indicators
2026-11-05 13:12:56Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has reported a flat financial performance for the quarter ended September 2026 despite recording its highest-ever quarterly net sales and profit after tax. The company’s recent financial trend has shifted from positive to flat, reflecting a mixed bag of operational strengths and emerging challenges that investors should carefully consider.
Read More
Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 2050
2026-11-05 10:14:08With a decisive break above Rs 2050 on 5 Nov 2026, Dr Lal Pathlabs Ltd has reached a fresh 52-week high, extending its impressive 27.19% return over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex is also trading near recent peaks.
Read More
Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 2013.6
2026-11-04 15:13:20With a decisive surge to an intraday peak of Rs 2013.6 on 4 Nov 2026, Dr Lal Pathlabs Ltd has nearly touched its 52-week high, closing just 1.06% shy of the Rs 2035 mark. This rally reflects a strong alignment of technical indicators and sustained price momentum, underscoring the stock’s robust upward trajectory amid a broadly positive market backdrop.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
13-Nov-2026 | Source : BSENewspaper Publication
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
12-Nov-2026 | Source : BSEAttached
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11-Nov-2026 | Source : BSEAttached
Corporate Actions
No Upcoming Board Meetings
Dr Lal Pathlabs Ltd has declared 50% dividend, ex-date: 11 Nov 26
No Splits history available
No Bonus history available
No Rights history available